Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, heating, and injecting. The company offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-10 Kuhlmann Shirley R. EVP and General Counsel Sell 7,000 $22.77 $159,390 No
2021-03-15 Heffernan Michael Thomas Director Sell 50,075 $25.30 $1,266,774 No
2021-03-01 Ciaffoni Joseph President and CEO Sell 64,768 $22.67 $1,468,425 Yes
2021-03-01 Fleming Alison B Chief Technical Officer Sell 18,235 $22.60 $412,169 Yes
2021-02-11 Dreyer Scott EVP & Chief Commercial Officer Sell 7,898 $25.21 $199,132 No
2021-01-20 Kuhlmann Shirley R. EVP and General Counsel Sell 6,081 $24.45 $148,680 No
2021-01-20 Kuhlmann Shirley R. EVP and General Counsel Sell 6,081 $24.45 $148,680 Yes
2021-01-15 Dreyer Scott EVP & Chief Commercial Officer Sell 1,322 $22.89 $30,261 No
2021-01-07 Fleming Alison B Chief Technology Officer Sell 19,378 $22.17 $429,652 Yes
2020-12-03 Fleming Alison B Chief Technology Officer Sell 5,967 $19.24 $114,805 No
2020-10-15 Kuhlmann Shirley R. EVP and General Counsel Sell 7,060 $20.82 $146,989 No
2020-08-11 Heffernan Michael Thomas Director Sell 13,071 $19.13 $250,048 No
2020-07-13 Dreyer Scott EVP & Chief Commercial Officer Sell 1,429 $17.01 $24,307 No
2020-06-02 Ciaffoni Joseph President and CEO Sell 76,537 $21.45 $1,641,767 Yes
2020-05-18 Dreyer Scott EVP & Chief Commercial Officer Sell 8,000 $24.00 $192,000 Yes
2020-05-13 Heffernan Michael Thomas Director Sell 19,254 $21.63 $416,421 No
2020-05-13 Fleming Alison B Chief Technology Officer Sell 7,989 $21.67 $173,147 No
2020-05-13 Dreyer Scott EVP & Chief Commercial Officer Sell 4,434 $22.61 $100,253 No
2020-01-21 Heffernan Michael Thomas Director Sell 295,287 $21.93 $6,476,863 Yes
2020-01-14 Dreyer Scott EVP & Chief Commercial Officer Sell 1,321 $23.87 $31,532 No
2019-11-08 Hirsch David Director Sell 25,000 $19.33 $483,250 No
2019-11-08 Fleming Alison B Chief Technology Officer Sell 25,000 $19.44 $486,000 Yes
2019-11-07 Ciaffoni Joseph President and CEO Sell 64,821 $18.77 $1,216,774 Yes
2019-08-29 Hirsch David Director Sell 22,106 $11.65 $257,535 Yes
2019-07-15 Heffernan Michael Thomas Director Sell 25,000 $11.26 $281,500 No
2019-07-11 Dreyer Scott EVP & Chief Commercial Officer Sell 2,857 $12.31 $35,170 No
2019-06-17 Heffernan Michael Thomas Director Sell 25,000 $11.37 $284,246 No
2019-06-03 Ciaffoni Joseph President and CEO Sell 13,287 $11.56 $153,587 No
2019-05-15 Heffernan Michael Thomas Director Sell 25,000 $12.84 $321,042 No
2019-04-15 Heffernan Michael Thomas Director Sell 25,000 $15.09 $377,366 No

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.